Posted Aug 31, 2020 7:27 am PDT
- Canada has reached another two deals to supply prospective COVID 19 vaccines to Canadians
- The deal with Novavax will guarantee Canada up to 76-million doses of its vaccine, the company says
- Canada also signed a deal with company Johnson & Johnson
OTTAWA (NEWS 1130) – The Canadian government has reached two new preliminary deals to secure millions of doses of COVID-19 vaccines being developed by Johnson & Johnson and Novavax.
The two new agreements also come after Canada signed similar deals with pharmaceutical giant Pfizer and U.S.-based biotech firm Moderna in early August.
“Taken together, our vaccine agreements with Pfizer, Moderna, Novavax, and Johnson & Johnson will give Canada at least 88 million doses, with options to obtain tens of millions more,” Prime Minister Justin Trudeau said.
Pfizer and Moderna have already begun Phase 3 clinical trials.
The tentative agreement with Novovax will see up to 76 million doses of that company’s vaccine be procured by Canada, the biotech firm says in a release. The company says the two sides are expected to “finalize an advance purchase agreement” that will see Novavax start supplying doses of its vaccine candidate to Canada “beginning as early as the second quarter of 2021.”
The vaccine is currently being tested and is one of dozens around the globe in varying stages of human trials.
Full details visit: